BCa is a heterogeneous disease and its classification has been based on such parameters as histological characteristics (tumor size, histological degree, lymph node involvement), and the human epidermal growth factor receptor (HER2) status in conjunction with the analysis of the overall patient condition, body reactivity, and age [39]. The gene discussed is ERBB2; the disease is neoplasm.